$3.45 -$0.35 (-9.2%)

04:00 PM EDT on 09/19/19

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

Current Price $3.45 Mkt Cap $141.3M
Open $3.81 P/E Ratio 0.00
Prev. Close $3.80 Div. (Yield) $0.00 (0.0%)
Daily Range $3.32 - $3.85 Volume 5,552,341
52-Wk Range $1.13 - $8.39 Avg. Daily Vol. 19

Caps

How do you think NASDAQ:LXRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

246 Outperform
45 Underperform
 

All-Star Players

28 Outperform
11 Underperform
 

Wall Street

5 Outperform
1 Underperform
 

Top NASDAQ:LXRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.82)
Submitted February 03, 2014

Lexicon stock is declining but I think it's mostly a tidal effects related to a market correction and weakness in speculative sectors like s,mall cap biopharma. I've made my issues with Lexicon's valuation clear and the street as responded over and… More

Brosan (< 20)
Submitted January 28, 2011

With more less than 80c per share available in cash, LXRX will have a very hard time to keep their heads above water. The me-too compound, LX4211, seems to be stuck in the ground due to the lack of interest in the pharma community. Even it finds a… More

NASDAQ:LXRX VS S&P 500 (SPY)

Fools bullish on NASDAQ:LXRX are also bullish on:

Fools bearish on NASDAQ:LXRX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about LXRX.

Recs

0
Member Avatar FVelociraptor (99.91) Submitted: 7/29/2019 3:32:16 PM : Underperform Start Price: $1.69 NASDAQ:LXRX Score: -104.21

https://velociraptor.cc

Recs

0
Member Avatar TMFBigFrog (95.91) Submitted: 1/27/2019 3:24:16 PM : Outperform Start Price: $4.56 NASDAQ:LXRX Score: -38.69

Potential for decent recovery if its type one diabetes medicine is approved.

Recs

0
Member Avatar NHWeston102 (68.26) Submitted: 4/1/2016 9:28:44 AM : Outperform Start Price: $11.96 NASDAQ:LXRX Score: -118.54

A variety of breakthrough drugs which will likely clear FDA this year.

Leaderboard

Find the members with the highest scoring picks in LXRX.

Score Leader

sglubis2

sglubis2 (97.72) Score: +267.63

The Score Leader is the player with the highest score across all their picks in LXRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
sglubis2 97.72 9/16/2009 Underperform 3M $19.60 -82.40% +185.23% +267.63 0 Comment
abedamri < 20 10/22/2009 Underperform 5Y $10.71 -67.79% +177.90% +245.69 0 Comment
Korodas 69.44 9/1/2010 Underperform NS $10.43 -66.92% +178.08% +245.00 0 Comment
stockjock11 < 20 1/20/2010 Underperform NS $16.94 -79.63% +165.23% +244.86 0 Comment
longtermgrowth09 < 20 12/17/2009 Underperform 5Y $12.60 -72.62% +172.03% +244.65 0 Comment
radmtom < 20 1/20/2010 Underperform 1Y $16.73 -79.38% +165.25% +244.63 0 Comment
str8nuts < 20 1/19/2010 Underperform 3W $13.65 -74.73% +161.77% +236.49 0 Comment
foolstracker < 20 3/8/2010 Underperform 5Y $11.55 -70.13% +163.60% +233.73 0 Comment
chuckyd5737 < 20 9/18/2006 Underperform 3M $26.39 -86.93% +142.30% +229.22 0 Comment
IceNineTX < 20 11/27/2006 Underperform 3M $27.02 -87.23% +128.02% +215.25 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackPoisedTo < 20 7/20/2012 Underperform 5Y $19.46 -82.27% +119.93% +202.20 0 Comment
TrackPoisedTo < 20 2/8/2012 Underperform 5Y $12.04 +65.70% +2.05% -63.64 7/19/2012 @ $19.95 0 Comment
TrackNeedham 89.99 5/27/2011 Outperform NS $10.64 -67.58% +125.83% -193.41 0 Comment
TrackWedbush 88.37 4/26/2011 Outperform NS $11.97 -71.18% +124.68% -195.86 0 Comment
TrackWayneRogers 47.81 1/7/2011 Outperform 3M $14.00 -75.36% +136.90% -212.25 0 Comment
TrackZacks < 20 10/21/2008 Outperform 3M $10.99 -18.47% +14.04% -32.51 7/13/2010 @ $8.96 1 Comment
TrackZacks < 20 5/1/2008 Outperform 3M $14.70 -32.38% -29.98% -2.40 10/20/2008 @ $9.94 1 Comment
TrackEveillard 92.62 12/31/2007 Outperform NS $21.21 -83.73% +114.69% -198.43 1 Comment
TrackPZK < 20 8/7/2007 Outperform NS $21.77 -48.87% -6.60% -42.28 4/17/2012 @ $11.13 0 Comment
TrackBofASec 91.73 5/15/2007 Outperform NS $23.66 -85.42% +111.30% -196.72 0 Comment
TrackPiperJaff 86.37 2/22/2007 Outperform NS $29.05 -62.41% -10.81% -51.60 3/7/2008 @ $10.92 0 Comment
TrackRBCCapMkts 84.20 1/30/2007 Outperform NS $25.97 0% +8.01% -8.01 10/31/2007 @ $25.97 0 Comment